دورية أكاديمية
Telepharmacy Implementation to Support Pharmaceutical Care Services during the COVID-19 Pandemic: A Scoping Review.
| العنوان: | Telepharmacy Implementation to Support Pharmaceutical Care Services during the COVID-19 Pandemic: A Scoping Review. |
|---|---|
| المؤلفون: | Sarasmita MA; MClinPharm, is with the Pharmacy Study Program, Faculty of Mathematics and Science, Udayana University, Badung City, Bali Province, Indonesia, and the Department of Clinical Pharmacy, School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan., Sudarma IW; MD, is with the Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Sanglah General Hospital, Bali, Indonesia., Jaya MKA; MClinPharm, is with the Pharmacy Study Program, Faculty of Mathematics and Science, Udayana University, Badung City, Bali Province, Indonesia., Irham LM; PhD, is with the Faculty of Pharmacy, University of Ahmad Dahlan, Yogyakarta, Indonesia, and the Research Center for Computing, Research Organization for Electronics and Informatics, National Research and Innovation Agency (BRIN), Republic of Indonesia, Cibinong Science Center, Cibinong, Indonesia., Susanty S; is with the Nursing Study Program, Faculty of Medicine, Halu Oleo University, Kendari, Southeast Sulawesi, Indonesia. |
| المصدر: | The Canadian journal of hospital pharmacy [Can J Hosp Pharm] 2024 Jan 10; Vol. 77 (1), pp. e3430. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2024). |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Canadian Society Of Hospital Pharmacists Country of Publication: Canada NLM ID: 0215645 Publication Model: eCollection Cited Medium: Internet ISSN: 1920-2903 (Electronic) Linking ISSN: 00084123 NLM ISO Abbreviation: Can J Hosp Pharm Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: Ottawa, Ontario : Canadian Society Of Hospital Pharmacists Original Publication: Saskatoon, Canadian Society of Hospital Pharmacists. |
| مستخلص: | Background: Telepharmacy was effectively applied for remote pharmaceutical care during the COVID-19 pandemic. Objectives: To determine the implementation of telepharmacy services to support pharmacists in providing pharmaceutical care during the pandemic. Data Sources: Seven electronic databases were searched from inception to June 2021: PubMed, Ovid MEDLINE, Excerpta Medica database (Embase), Web of Science, Proquest, Scopus, and the Cochrane Database of Systematic Reviews. Study Selection and Data Extraction: The review followed PRISMA guidelines and was registered with the PROSPERO registry of systematic reviews. Reports of original research investigating the implementation of telepharmacy during the COVID-19 pandemic were retrieved. Researchers screened the title and abstract of each article, and then evaluated the full text of eligible articles to identify studies that met the inclusion criteria. Pharmacists' responsibilities and actions were classified in relation to the International Pharmaceutical Federation guideline for managing the COVID-19 pandemic. Extracted data included study characteristics, pharmacists' interventions delivered through a telepharmacy system, and the benefits of telepharmacy implementation. Data Synthesis: The database search yielded 1400 articles. After removal of duplicates and articles not meeting the specific inclusion criteria (n = 1381), a total of 19 relevant original research articles were reviewed. According to these studies, telepharmacy was used to perform remote medication review and optimization, assess medication adherence, dispense and deliver medications, educate and counsel patients, promote disease prevention, collaborate with health care providers, and monitor treatment outcomes. Conclusions: This study highlighted the use of telepharmacy services to support pharmacists' activities during the COVID-19 pandemic. Randomized clinical trials are needed to investigate the long-term efficacy and cost-effectiveness of telepharmacy services. Competing Interests: Competing interests: None declared. (2024 Canadian Society of Hospital Pharmacists. All content in the Canadian Journal of Hospital Pharmacy is copyrighted by the Canadian Society of Hospital Pharmacy. In submitting their manuscripts, the authors transfer, assign, and otherwise convey all copyright ownership to CSHP.) |
| References: | Chron Respir Dis. 2016 May;13(2):192-203. (PMID: 26902542) Res Social Adm Pharm. 2021 Jan;17(1):1799-1806. (PMID: 33317760) Comput Biol Med. 2021 Nov;138:104878. (PMID: 34592585) Healthcare (Basel). 2022 Aug 26;10(9):. (PMID: 36141242) Int J Clin Pract. 2021 Aug;75(8):e14271. (PMID: 33894041) Res Social Adm Pharm. 2021 Jan;17(1):1813-1818. (PMID: 32278766) Br J Gen Pract. 2003 Mar;53(488):204-9. (PMID: 14694696) J Am Coll Clin Pharm. 2020 Sep;3(6):1129-1137. (PMID: 32838219) Farm Hosp. 2020 Jun 13;44(7):61-65. (PMID: 32533674) J Clin Pharm Ther. 2021 Feb;46(1):236-239. (PMID: 33085800) Enferm Infecc Microbiol Clin. 2023 Mar;41(3):149-154. (PMID: 34456409) Appl Clin Inform. 2020 May;11(3):452-459. (PMID: 32610350) J Am Coll Clin Pharm. 2021 Aug;4(8):914-923. (PMID: 34518813) Harm Reduct J. 2020 Nov 17;17(1):88. (PMID: 33203460) J Am Pharm Assoc (2003). 2021 May-Jun;61(3):331-339. (PMID: 33676838) Pharm Pract (Granada). 2017 Oct-Dec;15(4):1134. (PMID: 29317927) Can Pharm J (Ott). 2020 Aug 20;153(5):252-255. (PMID: 33110461) Eur J Hosp Pharm. 2021 Nov;28(Suppl 2):e120-e123. (PMID: 33115800) J Med Internet Res. 2020 May 22;22(5):e19434. (PMID: 32401215) Health Soc Care Community. 2022 Sep;30(5):e1639-e1650. (PMID: 34582591) Telemed J E Health. 2012 Sep;18(7):530-7. (PMID: 22822940) J Oncol Pharm Pract. 2012 Sep;18(3):366-76. (PMID: 22378811) J Pharm Policy Pract. 2020 Apr 20;13:8. (PMID: 32328285) J Am Pharm Assoc (2003). 2020 Nov - Dec;60(6):e113-e115. (PMID: 32839136) Int J Clin Pract. 2021 Oct;75(10):e14563. (PMID: 34165849) J Am Coll Clin Pharm. 2020 Dec;3(8):1480-1492. (PMID: 33043280) J Pharm Policy Pract. 2020 May 27;13:23. (PMID: 32501410) Can J Hosp Pharm. 2021 Summer;74(3):256-268. (PMID: 34248166) J Med Syst. 2020 Jun 15;44(7):132. (PMID: 32542571) J Oncol Pharm Pract. 2021 Apr;27(3):650-657. (PMID: 33554738) J Telemed Telecare. 2023 Apr;29(3):165-176. (PMID: 33377820) Prev Chronic Dis. 2020 Jul 30;17:E74. (PMID: 32730199) PLoS One. 2019 Dec 26;14(12):e0227132. (PMID: 31877194) J Am Pharm Assoc (2003). 2020 May - Jun;60(3):431-438.e1. (PMID: 32336673) J Pharm Pract. 2023 Apr;36(2):227-237. (PMID: 34275381) Integr Pharm Res Pract. 2016 Oct 26;5:75-82. (PMID: 29354542) Res Social Adm Pharm. 2021 Jan;17(1):1807-1812. (PMID: 32546449) Int J Clin Pharm. 2020 Apr;42(2):299-304. (PMID: 32222911) J Interprof Care. 2020 Sep-Oct;34(5):694-697. (PMID: 32917114) Farm Hosp. 2020 Jul 01;44(4):135-140. (PMID: 32646343) Pharmacy (Basel). 2020 Aug 07;8(3):. (PMID: 32784696) Front Pharmacol. 2021 Sep 09;12:652482. (PMID: 34566632) J Oncol Pharm Pract. 2020 Sep;26(6):1429-1440. (PMID: 32580641) Explor Res Clin Soc Pharm. 2021 Dec;4:100083. (PMID: 34723240) Healthc Manage Forum. 2022 May;35(3):153-160. (PMID: 35083937) J Pharm Pract. 2020 Apr;33(2):176-182. (PMID: 30060679) J Telemed Telecare. 2023 Jan;29(1):18-27. (PMID: 33059541) Res Social Adm Pharm. 2021 Jan;17(1):1967-1977. (PMID: 32389631) J Med Internet Res. 2020 Jul 2;22(7):e19514. (PMID: 32568727) Ir J Psychol Med. 2020 Sep;37(3):198-203. (PMID: 32434603) BMJ. 2021 Mar 29;372:n160. (PMID: 33781993) J Pharm Technol. 2020 Oct;36(5):171-178. (PMID: 34752571) Pharmacy (Basel). 2021 Nov 11;9(4):. (PMID: 34842823) J Am Pharm Assoc (2003). 2021 Sep-Oct;61(5):e119-e125. (PMID: 33931355) Res Social Adm Pharm. 2022 Aug;18(8):3338-3349. (PMID: 34924315) Pharm Pract (Granada). 2022 Jan-Mar;20(1):2609. (PMID: 35497899) World Neurosurg. 2020 Jul;139:549-557. (PMID: 32426065) Am J Health Syst Pharm. 2021 Feb 19;78(5):371-375. (PMID: 33279950) Res Social Adm Pharm. 2021 Jan;17(1):1929-1933. (PMID: 33317767) |
| فهرسة مساهمة: | Keywords: COVID-19; hospital pharmacy; pharmacist; telemedicine; telepharmacy Local Abstract: [Publisher, French] La télépharmacie a été efficacement utilisée pour les soins pharmaceutiques à distance pendant la pandémie de COVID-19. [Publisher, French] Déterminer comment des services de télépharmacie ont été mis en place pour soutenir les pharmaciens dans la prestation de leurs soins. [Publisher, French] Sept bases de données électroniques ont été utilisées pour effectuer les recherches, pour la période allant du début jusqu’à juin 2021: PubMed, Ovid MEDLINE, Excerpta Medica (Embase), Web of Science, Proquest, Scopus et la Cochrane Database of Systematic Reviews. [Publisher, French] L’examen suivait les lignes directrices PRISMA et a été enregistré dans le registre PROSPERO des revues systématiques. Des articles rapportant des recherches originales sur la mise en œuvre de la télépharmacie pendant la pandémie de COVID-19 ont été extraits. Les chercheurs ont examiné le titre et le résumé de chaque article avant d’évaluer le texte intégral des articles admissibles pour identifier les études répondant aux critères d’inclusion. Les responsabilités et les actes des pharmaciens ont été classés selon les lignes directrices de la Fédération internationale pharmaceutique relativement à la gestion de la pandémie de COVID-19. Les données extraites comprenaient les caractéristiques de l’étude, les interventions des pharmaciens effectuées au moyen du système de télépharmacie ainsi que les avantages de la mise en œuvre de la télépharmacie. [Publisher, French] La recherche dans la base de données a rendu 1400 articles. Après suppression des doublons et des articles ne répondant pas strictement aux critères d’inclusion (n = 1381), 19 articles de recherche originaux pertinents ont été examinés. Selon ces études, la télépharmacie était utilisée pour effectuer l’examen à distance de médicaments et leur optimisation, évaluer l’observance de la médication, dispenser et administrer des médicaments, informer et conseiller les patients, promouvoir la prévention des maladies, collaborer avec les prestataires de soins de santé et surveiller les résultats du traitement. [Publisher, French] Cette étude a mis en évidence l’utilisation des services de télépharmacie pour soutenir les activités des pharmaciens pendant la pandémie de COVID-19. Des essais cliniques randomisés sont nécessaires pour étudier l’efficacité à long terme et la rentabilité des services de télépharmacie. |
| تواريخ الأحداث: | Date Created: 20240111 Latest Revision: 20240711 |
| رمز التحديث: | 20240711 |
| مُعرف محوري في PubMed: | PMC10754407 |
| DOI: | 10.4212/cjhp.3430 |
| PMID: | 38204502 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1920-2903 |
|---|---|
| DOI: | 10.4212/cjhp.3430 |